When are clinical trials of a given agent vs. placebo no longer appropriate or feasible? (Q53586717)

15 May 2018

title

When are clinical trials of a given agent vs. placebo no longer appropriate or feasible? (English)

1 reference

15 May 2018

1 reference

Temple RJ

1

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

15 May 2018

Contemporary Clinical Trials

published in

1 reference

15 May 2018

volume

18

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

613-20; discussion 661-6

1 reference

15 May 2018

Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900058-5

7 January 2021

10.1016/S0197-2456(97)00058-5

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018